speb/financial-data huggingface dataset:
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 9711000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Cash Financial: 263636000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 1000000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Change In Inventory: 300000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 1036000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Change In Payable: 4000000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Change In Receivables: -7800000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -2500000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Changes In Cash: 18600000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Common Stock: 70663000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 43412000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -100000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 18414000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 184883000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Current Assets: 495912000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 67075000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Current Debt: 69225000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 136300000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 690441000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Depreciation: 91700000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 91700000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 91620000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 91620000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 167992667.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.11
CIRSA.MC income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 18685000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — EBIT: 87165000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — EBITDA: 178865000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -1300000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — End Cash Position: 273400000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -88000000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Finished Goods: 386000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 121400000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 900000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 48419000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Goodwill: 1551027000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2527719000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 82040000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1958474000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Gross Profit: 391851000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Interest Expense: 34647000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 34647000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Interest Income: 1139000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 1139000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -48600000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Interest Received Cfi: 1100000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Inventory: 12986000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2447048000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -64600000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 20823000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 32341000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 103694000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 207011000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 2334411000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2541422000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -4300000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 32341000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 21934000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 1107457000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Minority Interest: 133268000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Minority Interests: -9379000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -11500000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -100000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Net Debt: 2130289000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -3100000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Net Income: 18685000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 18685000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 28064000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 18685000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 18685000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 36800000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 28064000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -36200000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Net Interest Income: -52518000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -4400000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -4300000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -4300000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -52518000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -4300000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Net PPE: 539901000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -13600000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -2484307000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 105197000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 214908000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 179806000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Normalized Income: 19401932.92
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 171200000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Operating Income: 87165000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Operating Revenue: 576734000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 167992667.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 28052000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 976692000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 53100000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: -3000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 126413000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Other Payable: 383809000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Other Properties: 252597000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Other Receivables: 95155000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 33103000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Other Special Charges: 941000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Payables: 554141000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1635000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Pretax Income: 36835000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 0.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -11500000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -36200000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -5000000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -13600000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Raw Materials: 10343000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 184883000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 91700000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Rent And Landing Fees: 10207000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 10207000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -4300000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -100000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Research And Development: 24000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 5418000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -356067000.00
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 600000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 21949000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Selling General And Administration: 70368000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Share Issued: 167992667.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Special Income Charges: -941000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 43412000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -2484307000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -224067.08
CIRSA.MC income_statement (quarterly, 2025-03-31) — Tax Provision: 8771000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
CIRSA.MC cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -5700000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Total Assets: 3751383000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2377823000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Total Debt: 2677722000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 176680000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Total Expenses: 489569000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3574703000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3255471000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2884262000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 12663000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 110889000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Total Unusual Items: -941000.00
CIRSA.MC income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -941000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 105998000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Work In Process: 2257000.00
CIRSA.MC balance_sheet (quarterly, 2025-03-31) — Working Capital: -194529000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — +Operating Expense: 391483000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — +Total Revenue: 629414000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 50023000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 179687000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 752109000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Basic Average Shares: 167992667.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Basic EPS: -0.06
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 262392000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Capital Stock: 83996000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 339737000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 379623000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Common Stock: 83996000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 648292000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 163101000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Current Assets: 598143000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 66645000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Current Debt: 58478000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 125123000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 640329000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 98165000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 98165000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 167992667.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.06
CIRSA.MC income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -10266000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — EBIT: 74830000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — EBITDA: 172995000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Goodwill: 1526674000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2431752000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Gross PPE: 531377000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Gross Profit: 466313000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Inventory: 16341000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2523072000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 77250000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 195747000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1816302000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2012049000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 22102000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Minority Interest: 115013000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Minority Interests: -4943000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Net Debt: 1535043000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Net Income: -10266000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -10266000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -5323000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -10266000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -10266000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -5323000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Net Interest Income: -52094000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -52094000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Net PPE: 531377000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -1783460000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 99874000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 190692000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 174116000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Normalized Income: -9425250.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Operating Income: 74830000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Operating Revenue: 629414000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 167959442.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 22492000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 905078000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 107527000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Other Payable: 378764000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Other Properties: 531377000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 39886000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Other Special Charges: 1121000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Payables: 515205000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Pretax Income: 21551000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 163101000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 98165000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Rent And Landing Fees: 97952000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 97952000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -94820000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Share Issued: 167959442.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Special Income Charges: -1121000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 648292000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -1783460000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -280250.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Tax Provision: 26874000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.25
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Total Assets: 3738396000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2464594000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Total Debt: 2137172000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 763305000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Total Expenses: 554584000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2975091000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 3140253000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2334762000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 86418000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Total Unusual Items: -1121000.00
CIRSA.MC income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -1121000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 109919000.00
CIRSA.MC balance_sheet (quarterly, 2025-09-30) — Working Capital: -42186000.00
CIRSA.MC income_statement (annual, 2025-12-31) — +Operating Expense: 854194000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — +Operating Expense: -276402000.00
CIRSA.MC income_statement (annual, 2025-12-31) — +Total Revenue: 2339241000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — +Total Revenue: 469365000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Accounts Payable: 112417000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 112417000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Accounts Receivable: 41434000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 41434000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1462785000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1462785000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 752109000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 752109000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -25955000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -25955000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 19266000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 19266000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Basic Average Shares: 154252998.00
CIRSA.MC income_statement (annual, 2025-12-31) — Basic EPS: 0.47
CIRSA.MC cash_flow (annual, 2025-12-31) — Beginning Cash Position: 256094000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 239900.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 516308000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 516308000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Capital Expenditure: -214928000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -214781000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 280915000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 280915000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Capital Stock: 83996000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Capital Stock: 83996000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 313074000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 313074000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 373300000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 373300000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -44230000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -43976600.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Cash Equivalents: 10626000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 10626000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Cash Financial: 302447000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Cash Financial: 302447000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Change In Inventory: 929000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Change In Inventory: 928100.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 5167000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Change In Payable: 2374000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Change In Payable: 2372900.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Change In Receivables: 28276000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Change In Receivables: 28281900.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Change In Working Capital: 36746000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 36761300.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Changes In Cash: 60367000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Changes In Cash: 60375800.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Common Stock: 83996000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Common Stock: 83996000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Common Stock Equity: 711419000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 711419000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Common Stock Issuance: 677283000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 677283000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Construction In Progress: 14343000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 14343000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Cost Of Revenue: 1040272000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 543050000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Current Assets: 565664000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Current Assets: 565664000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 73855000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 73855000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Current Debt: 80245000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Current Debt: 80245000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 154100000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 154100000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Current Liabilities: 636601000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 636601000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Depreciation: 356381000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Depreciation: 356120000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 356381000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 356120000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 360381000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 94447000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Depreciation Income Statement: 360381000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 94447000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Diluted Average Shares: 154252998.00
CIRSA.MC income_statement (annual, 2025-12-31) — Diluted EPS: 0.47
CIRSA.MC income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 72937000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 56817000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 10309000.00
CIRSA.MC income_statement (annual, 2025-12-31) — EBIT: 409334000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — EBIT: 167276000.00
CIRSA.MC income_statement (annual, 2025-12-31) — EBITDA: 769715000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — EBITDA: 523396000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -3389000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -3386500.00
CIRSA.MC cash_flow (annual, 2025-12-31) — End Cash Position: 313074000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — End Cash Position: 313074000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Financing Cash Flow: -149078000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -148836600.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Finished Goods: 284000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Finished Goods: 284000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Free Cash Flow: 476643000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 476353100.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -713000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -715100.00
CIRSA.MC income_statement (annual, 2025-12-31) — General And Administrative Expense: 169580000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Goodwill: 1574274000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Goodwill: 1574274000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 2565605000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 2565605000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 67389000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 67389000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Gross PPE: 2032232000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2032232000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Gross Profit: 1298969000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Gross Profit: -73685000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Interest Expense: 223380000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 223380000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Interest Income: 10309000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Interest Income Non Operating: 10309000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Interest Paid Cff: -177707000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -177563300.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Interest Received Cfi: 10309000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Interest Received Cfi: 10303600.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Inventory: 12888000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Inventory: 12888000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Invested Capital: 2629302000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2629302000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Investing Cash Flow: -482126000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -481921700.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 19266000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 19266000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Investmentsin Associatesat Cost: 25361000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 25361000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 677283000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 677283000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Issuance Of Debt: 993222000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 992569500.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Land And Improvements: 109412000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 109412000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 207060000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 207060000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Long Term Debt: 1837638000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1837638000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2044698000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2044698000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 993222000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 992569500.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1522500000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -1522062500.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 25361000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 25361000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Long Term Provisions: 22227000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 22227000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1136211000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1136211000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Minority Interest: 106560000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Minority Interest: 106560000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Minority Interests: -44631000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Minority Interests: -24088000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -255787000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -255720200.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Net Debt: 1604809000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Net Debt: 1604809000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -8978000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -8980700.00
CIRSA.MC income_statement (annual, 2025-12-31) — Net Income: 72937000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Net Income: 56817000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 72937000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 56817000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 117568000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 80905000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 72937000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 56817000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 72937000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 56817000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 185954000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 185869300.00
CIRSA.MC income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 117568000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 80905000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -127077000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -127017300.00
CIRSA.MC income_statement (annual, 2025-12-31) — Net Interest Income: -267260000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Net Interest Income: -114674000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -21720000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -21724100.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -529278000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -529493000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -529278000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -529493000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -267260000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -114674000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 684822000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -27016000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Net PPE: 569447000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Net PPE: 569447000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -87851000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -87763700.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -1854186000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -1854186000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 89277000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 89277000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 210492000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 210492000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Normalized EBITDA: 777530000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 529138000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Normalized Income: 77877974.22
CIRSA.MC income_statement (quarterly, 2025-12-31) — Normalized Income: 61403355.25
CIRSA.MC cash_flow (annual, 2025-12-31) — Operating Cash Flow: 691571000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 691134100.00
CIRSA.MC income_statement (annual, 2025-12-31) — Operating Income: 444775000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Operating Income: 202717000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Operating Revenue: 2339241000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Operating Revenue: 469365000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 167959442.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 167959442.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: 2000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Other Current Assets: 22963000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 22963000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 391990000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 391990000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 991331000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 991331000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Other Non Cash Items: 205794000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 205642500.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: -1000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: -1000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Other Operating Expenses: 134400000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -174784000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Other Payable: 230774000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Other Payable: 230774000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Other Properties: 255958000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Other Properties: 255958000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Other Receivables: 113879000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Other Receivables: 113879000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 60226000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 60226000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Other Special Charges: -714000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Other Special Charges: -2787000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Payables: 482501000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Payables: 482501000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Prepaid Assets: 1200000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 1200000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Pretax Income: 185954000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Pretax Income: 101291000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Properties: 0.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 4116000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 4111000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Purchase Of Business: -255787000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -255720200.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -127077000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -127017300.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Purchase Of Investment: -27016000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -27011800.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Purchase Of PPE: -87851000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -87763700.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Raw Materials: 11416000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Raw Materials: 11416000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1040272000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 543050000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Reconciled Depreciation: 356381000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 356120000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Rent And Landing Fees: 41901000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Rent And Landing Fees: -263841000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 41901000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: -263841000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1522500000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -1522062500.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
CIRSA.MC income_statement (annual, 2025-12-31) — Research And Development: 129000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 8529000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Retained Earnings: -53007000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -53007000.00
CIRSA.MC cash_flow (annual, 2025-12-31) — Sale Of Investment: 5296000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 5287700.00
CIRSA.MC income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 86221000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Selling General And Administration: 255801000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Share Issued: 167992667.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Share Issued: 167992667.00
CIRSA.MC income_statement (annual, 2025-12-31) — Special Income Charges: -7815000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Special Income Charges: -5742000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Stockholders Equity: 711419000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 711419000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Tangible Book Value: -1854186000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -1854186000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -2874025.78
CIRSA.MC income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -1155644.75
CIRSA.MC income_statement (annual, 2025-12-31) — Tax Provision: 68386000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Tax Provision: 20386000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.37
CIRSA.MC income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.20
CIRSA.MC cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -91729000.00
CIRSA.MC cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -91674200.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Total Assets: 3863154000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Total Assets: 3863154000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Total Capitalization: 2549057000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 2549057000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Total Debt: 2198798000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Total Debt: 2198798000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 817979000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 817979000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Total Expenses: 1894466000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Total Expenses: 266648000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3045175000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3045175000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 3297490000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 3297490000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2408574000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 2408574000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 746554000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Total Other Finance Cost: 54189000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Total Tax Payable: 139310000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 139310000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Total Unusual Items: -7815000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Total Unusual Items: -5742000.00
CIRSA.MC income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -7815000.00
CIRSA.MC income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -5742000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 131158000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 131158000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 33225.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 33225.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Treasury Stock: 413000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 413000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Work In Process: 1188000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Work In Process: 1188000.00
CIRSA.MC balance_sheet (annual, 2025-12-31) — Working Capital: -70937000.00
CIRSA.MC balance_sheet (quarterly, 2025-12-31) — Working Capital: -70937000.00
CIRSA.MC income_statement (quarterly, 2026-03-31) — +Operating Expense: 327562000.00
CIRSA.MC income_statement (quarterly, 2026-03-31) — +Total Revenue: 622976000.00
CIRSA.MC balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 60821000.00
CIRSA.MC balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 147925000.00
CIRSA.MC balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 752109000.00
CIRSA.MC income_statement (quarterly, 2026-03-31) — Basic Average Shares: 167912577.00
CIRSA.MC income_statement (quarterly, 2026-03-31) — Basic EPS: 0.21
CIRSA.MC cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 313100000.00